Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

European Biological Variation Study (EuBIVAS): Within- and Between-Subject Biological Variation Data for 15 Frequently Measured Proteins.

Carobene A, Aarsand AK, Guerra E, Bartlett WA, Coŝkun A, Díaz-Garzón J, Fernandez-Calle P, Jonker N, Locatelli M, Sandberg S, Ceriotti F; European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation.

Clin Chem. 2019 Jun 6. pii: clinchem.2019.304618. doi: 10.1373/clinchem.2019.304618. [Epub ahead of print]

PMID:
31171528
2.

Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC).

Díaz-Garzón J, Fernández-Calle P, Minchinela J, Aarsand AK, Bartlett WA, Aslan B, Boned B, Braga F, Carobene A, Coskun A, Gonzalez-Lao E, Jonker N, Marques-Garcia F, Perich C, Ricos C, Simón M, Sandberg S.

Clin Chim Acta. 2019 Aug;495:467-475. doi: 10.1016/j.cca.2019.05.013. Epub 2019 May 16. Review.

PMID:
31103621
3.

Systematic review of the biological variation data for diabetes related analytes.

González-Lao E, Corte Z, Simón M, Ricós C, Coskun A, Braga F, Aarsand AK, Carobene A, Bartlett WA, Boned B, Asland B, Díaz-Garzón J, Marqués-García F, Minchinela J, Perich C, Fernández-Calle P, Roraas T, Fernández-Fernández P, Jonker N, Sandberg S; European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and Task Group for the Biological Variation Database.

Clin Chim Acta. 2019 Jan;488:61-67. doi: 10.1016/j.cca.2018.10.031. Epub 2018 Oct 31.

PMID:
30389455
4.

The EuBIVAS: Within- and Between-Subject Biological Variation Data for Electrolytes, Lipids, Urea, Uric Acid, Total Protein, Total Bilirubin, Direct Bilirubin, and Glucose.

Aarsand AK, Díaz-Garzón J, Fernandez-Calle P, Guerra E, Locatelli M, Bartlett WA, Sandberg S, Røraas T, Ceriotti F, Sølvik UØ, Sverresdotter Sylte M, Coşkun A, Serteser M, Unsal I, Tosato F, Plebani M, Jonker N, Barla G, Carobene A; European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation.

Clin Chem. 2018 Sep;64(9):1380-1393. doi: 10.1373/clinchem.2018.288415. Epub 2018 Jun 25.

PMID:
29941472
5.

Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects.

Coşkun A, Carobene A, Kilercik M, Serteser M, Sandberg S, Aarsand AK, Fernandez-Calle P, Jonker N, Bartlett WA, Díaz-Garzón J, Huet S, Kızıltaş C, Dalgakıran I, Ugur E, Unsal I; European Biological Variation Study of the EFLM Working Group on Biological Variation.

Clin Chem Lab Med. 2018 Jul 26;56(8):1309-1318. doi: 10.1515/cclm-2017-1155.

6.

Harmonization initiatives in the generation, reporting and application of biological variation data.

Aarsand AK, Røraas T, Bartlett WA, Coşkun A, Carobene A, Fernandez-Calle P, Jonker N, Díaz-Garzón J, Braga F, Sandberg S; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group on Biological Variation.

Clin Chem Lab Med. 2018 Sep 25;56(10):1629-1636. doi: 10.1515/cclm-2018-0058. Review. No abstract available.

7.

The Biological Variation Data Critical Appraisal Checklist: A Standard for Evaluating Studies on Biological Variation.

Aarsand AK, Røraas T, Fernandez-Calle P, Ricos C, Díaz-Garzón J, Jonker N, Perich C, González-Lao E, Carobene A, Minchinela J, Coşkun A, Simón M, Álvarez V, Bartlett WA, Fernández-Fernández P, Boned B, Braga F, Corte Z, Aslan B, Sandberg S; European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and Task and Finish Group for the Biological Variation Database.

Clin Chem. 2018 Mar;64(3):501-514. doi: 10.1373/clinchem.2017.281808. Epub 2017 Dec 8.

8.

The EuBIVAS Project: Within- and Between-Subject Biological Variation Data for Serum Creatinine Using Enzymatic and Alkaline Picrate Methods and Implications for Monitoring.

Carobene A, Marino I, Coşkun A, Serteser M, Unsal I, Guerra E, Bartlett WA, Sandberg S, Aarsand AK, Sylte MS, Røraas T, Sølvik UØ, Fernandez-Calle P, Díaz-Garzón J, Tosato F, Plebani M, Jonker N, Barla G, Ceriotti F; European Biological Variation Study of the EFLM Working Group on Biological Variation.

Clin Chem. 2017 Sep;63(9):1527-1536. doi: 10.1373/clinchem.2017.275115. Epub 2017 Jul 18.

9.

Biological Variation Estimates Obtained from 91 Healthy Study Participants for 9 Enzymes in Serum.

Carobene A, Røraas T, Sølvik UØ, Sylte MS, Sandberg S, Guerra E, Marino I, Jonker N, Barla G, Bartlett WA, Fernandez-Calle P, Díaz-Garzón J, Tosato F, Plebani M, Coşkun A, Serteser M, Unsal I, Ceriotti F; European Biological Variation Study of the EFLM Working Group on Biological Variation.

Clin Chem. 2017 Jun;63(6):1141-1150. doi: 10.1373/clinchem.2016.269811. Epub 2017 Apr 20.

10.

Sample collections from healthy volunteers for biological variation estimates' update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine.

Carobene A, Strollo M, Jonker N, Barla G, Bartlett WA, Sandberg S, Sylte MS, Røraas T, Sølvik UØ, Fernandez-Calle P, Díaz-Garzón J, Tosato F, Plebani M, Coşkun A, Serteser M, Unsal I, Ceriotti F; Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem Lab Med. 2016 Oct 1;54(10):1599-608. doi: 10.1515/cclm-2016-0035.

11.

A checklist for critical appraisal of studies of biological variation.

Bartlett WA, Braga F, Carobene A, Coşkun A, Prusa R, Fernandez-Calle P, Røraas T, Jonker N, Sandberg S; Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine (EFLM).

Clin Chem Lab Med. 2015 May;53(6):879-85. doi: 10.1515/cclm-2014-1127.

12.

Biological variation: a still evolving facet of laboratory medicine.

Simundic AM, Bartlett WA, Fraser CG.

Ann Clin Biochem. 2015 Mar;52(Pt 2):189-90. doi: 10.1177/0004563214567478. Epub 2015 Jan 20. No abstract available.

PMID:
25605975
13.

A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferase.

Carobene A, Braga F, Roraas T, Sandberg S, Bartlett WA.

Clin Chem Lab Med. 2013 Oct;51(10):1997-2007. doi: 10.1515/cclm-2013-0096. Review.

PMID:
24072574
14.

Reflex and reflective testing: efficiency and effectiveness of adding on laboratory tests.

Srivastava R, Bartlett WA, Kennedy IM, Hiney A, Fletcher C, Murphy MJ.

Ann Clin Biochem. 2010 May;47(Pt 3):223-7. doi: 10.1258/acb.2010.009282. Epub 2010 Apr 14.

PMID:
20392754
15.

Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease.

Al-Daghri N, Al-Rubean K, Bartlett WA, Al-Attas O, Jones AF, Kumar S.

Diabet Med. 2003 Oct;20(10):832-7.

PMID:
14510865
16.

11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone.

Cooper MS, Blumsohn A, Goddard PE, Bartlett WA, Shackleton CH, Eastell R, Hewison M, Stewart PM.

J Clin Endocrinol Metab. 2003 Aug;88(8):3874-7.

PMID:
12915682
17.

Association between the cholesteryl ester transfer protein TaqI-detectable B polymorphism and low high-density lipoprotein cholesterol concentration in Saudis.

Al-Daghri NM, Al-Attas O, Patel A, Belyaev ND, Bartlett WA, Jones AF, Kumar S, Bain SC.

Clin Sci (Lond). 2003 Oct;105(4):467-72.

PMID:
12773093
18.

Cardiovascular risk assessment in patients with retinal vein occlusion.

Martin SC, Butcher A, Martin N, Farmer J, Dobson PM, Bartlett WA, Jones AF.

Br J Ophthalmol. 2002 Jul;86(7):774-6.

19.

Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.

Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM.

J Bone Miner Res. 2002 Jun;17(6):979-86.

20.

Role of leptin in glucose metabolism in type 2 diabetes.

Al-Daghri N, Bartlett WA, Jones AF, Kumar S.

Diabetes Obes Metab. 2002 May;4(3):147-55. Review. No abstract available.

PMID:
12047393
21.

Serum homocysteine concentration is related to diabetes mellitus, but not to coronary heart disease, in Saudi Arabians.

Al-Nozah M, Al-Daghri N, Bartlett WA, Al-Attas O, Al-Maatouq M, Martin SC, Kumar S, Jones AF.

Diabetes Obes Metab. 2002 Mar;4(2):118-23.

PMID:
11940109
22.

Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus.

Game FL, Bartlett WA, Bayly GR, Jones AF.

Diabetes Obes Metab. 2001 Aug;3(4):279-86.

PMID:
11520308
23.

The sleep apnoea/hypopnoea syndrome depresses waking vagal tone independent of sympathetic activation.

Hilton MF, Chappell MJ, Bartlett WA, Malhotra A, Beattie JM, Cayton RM.

Eur Respir J. 2001 Jun;17(6):1258-66.

24.

Laboratory-based calculation of coronary heart disease risk.

Geberhiwot T, Jones AF, Bartlett WA, Husband D, Martin SC.

Clin Chem. 2001 Mar;47(3):589-91. No abstract available.

25.

Comparative accuracy of cardiovascular risk prediction methods in primary care patients.

Jones AF, Walker J, Jewkes C, Game FL, Bartlett WA, Marshall T, Bayly GR.

Heart. 2001 Jan;85(1):37-43.

26.

Standardization of HbA1c measurements.

Bartlett WA, Jones AF, Hall RA, Legg EF.

Diabet Med. 2000 Jul;17(7):558-60. No abstract available.

PMID:
10972596
27.

Standardization of HbA1c measurements: a consensus statement.

Bartlett WA, Jones AF, Hall RA, Legg EF.

Ann Clin Biochem. 2000 Jul;37 ( Pt 4):549-51. No abstract available.

PMID:
10902876
28.

Laboratory-based calculation of coronary heart disease risk in a hospital diabetic clinic.

Bayly GR, Bartlett WA, Davies PH, Husband D, Haddon A, Game FL, Jones AF.

Diabet Med. 1999 Aug;16(8):697-701.

PMID:
10477217
29.

Plasma total homocysteine measurement by ion-paired reversed-phase HPLC with electrochemical detection.

Martin SC, Hilton AC, Bartlett WA, Jones AF.

Biomed Chromatogr. 1999 Feb;13(1):81-2.

PMID:
10191950
30.

Measurement of plasma total homocysteine by HPLC with coulometric detection.

Martin SC, Tsakas-Ampatzis I, Bartlett WA, Jones AF.

Clin Chem. 1999 Jan;45(1):150-2. No abstract available.

31.

Glomerular filtration rate determination in diabetic patients using iohexol clearance--comparison of single and multiple plasma sampling methods.

Chowdhury TA, Dyer PH, Bartlett WA, Legge ES, Durbin SM, Barnett AH, Bain SC.

Clin Chim Acta. 1998 Oct;277(2):153-8.

PMID:
9853698
32.

The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.

Ford C, Moore AJ, Jordan PA, Bartlett WA, Wyldes MP, Jones AF, MacKenzie WE.

Br J Obstet Gynaecol. 1998 Aug;105(8):855-9.

PMID:
9746377
33.

A non-isotopic method for estimating 11 beta hydroxysteroid dehydrogenase activity in vivo.

Bayly GR, Bartlett WA, Jones AF.

Ann Clin Biochem. 1997 Sep;34 ( Pt 5):521-6.

PMID:
9293306
34.

Effects of dietary sodium substitution with potassium and magnesium in hypertensive type II diabetics: a randomised blind controlled parallel study.

Gilleran G, O'Leary M, Bartlett WA, Vinall H, Jones AF, Dodson PM.

J Hum Hypertens. 1996 Aug;10(8):517-21.

PMID:
8895035
35.
36.
37.

Lipoprotein(a), ACE, and family history of CAD.

Payne MN, Bartlett WA, McDonald F, Murray RG, Beattie JM, Jones AF.

Circulation. 1995 Dec 15;92(12):3583. No abstract available.

PMID:
8521588
38.

Plasma angiotensin-converting enzyme activity and carotid wall thickening.

Payne MN, McDonald F, Murray RG, Bartlett WA, Jones AF, Beattie JM.

Circulation. 1994 Nov;90(5):2566-7; author reply 2567-8. No abstract available.

PMID:
7955223
39.

Serum screening for Down's syndrome. Vacutainer system can lead to inaccurate results.

Bartlett WA, Ford C, Jones AF.

BMJ. 1993 Oct 2;307(6908):868. No abstract available.

40.

Insulin resistance in syndrome X.

Saeed BT, Bartlett WA, Murray RG, Jones AF, Beattie JM.

Lancet. 1993 Aug 28;342(8870):555. No abstract available.

PMID:
8102690
41.

The acute effects of corticotropin-releasing factor on energy expenditure in lean and obese women.

Chong PK, Jung RT, Bartlett WA, Browning MC.

Int J Obes Relat Metab Disord. 1992 Jul;16(7):529-34.

PMID:
1323549
42.

Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism.

Hambling C, Jung RT, Gunn A, Browning MC, Bartlett WA.

Clin Endocrinol (Oxf). 1992 May;36(5):499-503.

PMID:
1617801
43.

Interference of fluorescein with creatinine assays.

Dick JB, Bartlett WA, Ibrahim U, Coleiro JA.

Ann Clin Biochem. 1991 May;28 ( Pt 3):311-3. No abstract available.

PMID:
1872582
46.

Interference by acetic acid in urinary 5-hydroxyindoleacetic acid determination.

Deacon AC, Bartlett WA.

Clin Chem. 1982 Jan;28(1):250-1. No abstract available.

47.

Dose regimens of human growth hormone: effects of continuous infusion and of a gelatin vehicle on growth in rats and rate of absorption in rabbits.

Cotes PM, Bartlett WA, Gaines Das RE, Flecknell P, Termeer R.

J Endocrinol. 1980 Nov;87(2):303-12.

PMID:
7430924
48.

The effectiveness of meprobamate and lobeline as smoking deterrents.

BARTLETT WA, WHITEHEAD RW.

J Lab Clin Med. 1957 Aug;50(2):278-81. No abstract available.

PMID:
13449408

Supplemental Content

Loading ...
Support Center